MICROENVIRONMENT MODULATION BY TIM-3 BLOCKADE IMPROVES THE OUTCOME OF PRECLINICAL DIPG MODELS

被引:0
|
作者
Ausejo-Mauleon, Iker [1 ,2 ]
Labiano, Sara [1 ,2 ]
Laspidea, Virginia [1 ,2 ]
Garcia-Moure, Marc [1 ,2 ]
de la Nava, Daniel [1 ,2 ]
Puigdelloses, Montserrat [1 ,2 ]
Becher, Oren J. [3 ]
Jiang, Li [4 ]
Filbin, Mariella G. [4 ]
Pastor, Fernando [5 ]
Alonso, Marta M. [1 ,2 ]
机构
[1] Clin Univ Navarra, Dept Pediat, Navarra, Spain
[2] Hlth Res Inst Os Navarra IdiSNA, Navarra, Spain
[3] Ann & Robert H Lurie Childrens Hosp Chicago, Div Hematol Oncol Neurooncol & Stem Cell Transpla, Chicago, IL 60611 USA
[4] Dana Farber Boston Childrens Canc & Blood Disorde, Dept Pediat Oncol, Boston, MA USA
[5] Univ Navarra, CIMA, Ctr Appl Med Res, Mol Therapeut Program, Navarra, Spain
关键词
D O I
10.1093/neuonc/noab090.116
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
IMMU-08
引用
收藏
页码:28 / 28
页数:1
相关论文
共 50 条
  • [1] Modulation of tumor microenvironment with TIM-3 blockade improves survival in diffuse midline glioma models
    Ausejo-Mauleon, Iker
    Labiano, Sara
    Laspidea, Virginia
    de la Nava, Daniel
    Becher, Oren
    Filbin, Mariella G.
    Pastor, Fernando
    Alonso, Marta M.
    CANCER RESEARCH, 2023, 83 (07)
  • [2] TIM-3 BLOCKADE MODULATES THE TUMOR MICROENVIRONMENT IMPROVING THE OUTCOME OF PRECLINICAL PEDIATRIC DIFFUSE MIDLINE GLIOMA MODELS
    Ausejo-Mauleon, Iker
    Labiano, Sara
    Laspidea, Virginia
    Garcia-Moure, Marc
    de la Nava, Daniel
    Becher, Oren
    Filbin, Mariella
    Pastor, Fernando
    Alonso, Marta
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A307 - A307
  • [3] TIM-3 APTAMER IN COMBINATION WITH RADIOTHERAPY RESULTS IN ENHANCED SURVIVAL IN DIPG MODELS
    Martinez-Velez, Naiara
    Garcia-Moure, Marc
    Puigdelloses, Montserrat
    Laspidea, Virginia
    Ausejo, Iker
    Isaac Ramos, Luis
    Becher, Oren J.
    Pastor, Fernando
    Alonso, Marta M.
    NEURO-ONCOLOGY, 2020, 22 : 113 - 113
  • [4] Tim-3, a negative player in liver tumor microenvironment
    Ma, C.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 193 - 193
  • [5] Increased Tim-3 expression in peripheral NK cells predicts a poorer prognosis and Tim-3 blockade improves NK cell-mediated cytotoxicity in human lung adenocarcinoma
    Xu, Liyun
    Huang, Yanyan
    Tan, Linlin
    Yu, Wei
    Chen, Dongdong
    Lu, ChangChang
    He, Jianying
    Wu, Guoqing
    Liu, Xiaoguang
    Zhang, Yongkui
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2015, 29 (02) : 635 - 641
  • [6] Modulation of mast cell function by TIM-3 signaling
    Phong, Binh
    Kane, Lawrence
    JOURNAL OF IMMUNOLOGY, 2014, 192
  • [7] Reversal of natural killer cell exhaustion by TIM-3 blockade
    Gallois, Anne
    Silva, Ines
    Osman, Iman
    Bhardwaj, Nina
    ONCOIMMUNOLOGY, 2014, 3 (12) : 1 - 3
  • [8] Combination of locoregional radiotherapy with a TIM-3 aptamer improves survival in diffuse midline glioma models
    Ausejo-Mauleon, Iker
    Martinez-Velez, Naiara
    Lacalle, Andrea
    de la Nava, Daniel
    Cebollero, Javier
    Villanueva, Helena
    Casares, Noelia
    Marco-Sanz, Javier
    Laspidea, Virginia
    Becher, Oren
    Patino-Garcia, Ana
    Labiano, Sara
    Pastor, Fernando
    Alonso, Marta M.
    JCI INSIGHT, 2024, 9 (18)
  • [9] The Role of TIM-3 and LAG-3 in the Microenvironment and Immunotherapy of Ovarian Cancer
    Kozlowski, Mateusz
    Borzyszkowska, Dominika
    Cymbaluk-Ploska, Aneta
    BIOMEDICINES, 2022, 10 (11)
  • [10] Tim-3 blockade decreases the apoptosis of CD8+T cells and improves the survival of septic mice
    Bo, Lulong
    Wang, Changli
    Deng, Xiaoming
    ANESTHESIA AND ANALGESIA, 2021, 133 (3S_SUPPL): : 843 - 844